Extract notice to the Minister
Brukinsa (LLC et Waldenström)
Common name / Subject : zanubrutinib
Name of the manufacturer : BeiGene
Form : Co.
Dosage : 160 mg
Name of the manufacturer : BeiGene
Form : Co.
Dosage : 160 mg
Indication : Leucémie lymphoïde chronique, Macroglobulinémie de Waldenström
INESSS' Recommendation
Inscription - Sous conditions
Minister's decisions
À venir
Evaluation published on June 04, 2025